Records containing: High Grade Glioma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-10Phase II Clinical Trial of HSV G207 With a Single 5 Gy Radiation Dose in Children With Recurrent High-Grade Glioma
-
CLINICAL_TRIALS study record update · 2026-01-27HiLoGlio Organoid Study: 'A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors'
-
CLINICAL_TRIALS study record update · 2026-01-20Loc3CAR: Locoregional Delivery of B7-H3-specific Chimeric Antigen Receptor Autologous T Cells for Pediatric Patients With Primary CNS Tumors
-
CLINICAL_TRIALS study record update · 2026-01-14An Open Label, Phase 1b Safety, Dose-finding, Brain Tumor Delivery, and Pharmacokinetics Study of Intranasal NEO100 in Patients With Pediatric-type Select Brain Tumors
-
CLINICAL_TRIALS study record update · 2025-12-16Fluorescence Enhanced Stereotactic Surgery
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-11Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
-
CLINICAL_TRIALS study record update · 2025-12-04Evaluation of 18F-Fluciclovine PET-MRI to Differentiate Tumor Progression From Post-treatment Changes in Pediatric High-grade Glioma (HGG)
-
CLINICAL_TRIALS study record update · 2025-11-24Phase II Trial Evaluating Nivolumab In Patients With IDH-Mutant Gliomas With And Without Hypermutator Phenotype
-
CLINICAL_TRIALS study record update · 2025-11-20A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (HGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration With PK-triggered Expansion Cohort
-
CLINICAL_TRIALS study record update · 2025-11-10Phase II Study of Neoadjuvant Chemoradiation for Resectable Glioblastoma (NeoGlio)
-
CLINICAL_TRIALS study record update · 2025-09-16A Phase 1 Study of DSP-0390 in Patients With Recurrent High-Grade Glioma
-
CLINICAL_TRIALS study record update · 2025-09-04Phase I Study of Autologous T Lymphocytes Expressing GD2-specific Chimeric Antigen and Constitutively Active IL-7 Receptors for the Treatment of Patients With GD2-expressing Brain Tumors (GAIL-B)
-
CLINICAL_TRIALS study record update · 2025-08-29U-R-Immune Glioma (CA209-1245): A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)
-
CLINICAL_TRIALS study record update · 2025-07-08HUMC 1612: A Phase I Trial of the Optune NovoTTF-200A System With Concomitant Temozolomide and Bevacizumab in Pediatric Patients With High-grade Glioma
-
CLINICAL_TRIALS study record update · 2025-07-08BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels
-
CLINICAL_TRIALS study record update · 2025-06-22Synergistic Treatment With Antiretrovirals and Laser Interstitial Thermal thErapy (STARLITE) for Unresectable High-Grade Gliomas: A Phase 1 Study
-
CLINICAL_TRIALS study record update · 2025-06-19Expedited Laser Interstitial Thermal Therapy and Chemoradiation for Patients With Newly Diagnosed High Grade Gliomas
-
CLINICAL_TRIALS study record update · 2025-06-19A Phase 1 Multi-center Clinical Trial Evaluating the Safety and Tolerability of 5-aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy(SDT) in Patients With Recurrent High Grade Glioma (HGG)
-
CLINICAL_TRIALS study record update · 2025-06-17Ultrasound Imaging in Brain Tumour Surgery With the Use of SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
-
CLINICAL_TRIALS study record update · 2025-06-08A Phase 2 Trial for Patients With Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide, and BMX-001
-
CLINICAL_TRIALS study record update · 2025-06-05Contribution of Cerebral 18F-DOPA PET-CT Scan in High-grade Recurrent Gliomas : a Monocentric Pilot Impact Study on the Practices of Defining Target Volumes Before RAdiotherapy
-
CLINICAL_TRIALS study record update · 2025-06-0568Ga/177Lu-PSMA Theranostics in Recurrent Grade 3 and Grade 4 Glioma
-
CLINICAL_TRIALS study record update · 2025-05-29A Pilot Study Evaluating the Toxicity and Clinical Benefit of Mitogen-activated Protein Kinase (MAPK) Pathway Inhibition Combined With Programmed Cell Death-1 Checkpoint Blockade (Anti-PD1) for the Treatment of BRAF-altered Pediatric Gliomas
-
CLINICAL_TRIALS study record update · 2025-05-29A Biomarker-Guided Phase 2 Study of DB107-RRV (Retroviral Replicating Vector) Combined With DB107-Flucytosine Extended-Release Tablets in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
-
CLINICAL_TRIALS study record update · 2025-05-13Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells in Children and Young Adults With Recurrent, Progressive, or Refractory Brain Tumors